Aug 11, 2026 08:00AM
Aug 6, 2026 08:00AM
Aug 6, 2026 08:00AM
Jul 7, 2026 08:01AM
Jul 7, 2026 08:00AM
Jun 11, 2026 08:01AM
Jun 11, 2026 08:00AM Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research
May 5, 2026 04:30PM
May 8, 2025 04:30PM
May 7, 2025 09:20AM
May 7, 2025 09:17AM
Sep 27, 2024 06:03AM
Sep 26, 2024 09:06PM
Mar 25, 2024 07:30AM Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results
Aug 8, 2023 08:00AM
May 23, 2023 08:00AM
May 11, 2023 08:00AM
Mar 30, 2023 08:00AM
Nov 10, 2022 04:45PM
Oct 31, 2022 08:00AM
Oct 24, 2022 08:00AM Theriva Biologics Announces Presentation at the 14th International Oncolytic Virotherapy (IVOC) Conference Describing Phase 1 Investigator-sponsored Study Evaluating VCN-01 in Combination with Durvalu
Oct 12, 2022 08:04AM
Oct 12, 2022 08:00AM

1,180,394 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All